BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27848272)

  • 1. Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.
    Trevillyan JM; Gardiner EE; Andrews RK; Maisa A; Hearps AC; Al-Tamimi M; Crowe SM; Hoy JF
    Platelets; 2017 May; 28(3):301-304. PubMed ID: 27848272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis.
    Stack JR; Madigan A; Helbert L; Dunne E; Gardiner EE; Andrews RK; Finan R; Smyth E; Kenny D; McCarthy GM
    PLoS One; 2017; 12(11):e0188027. PubMed ID: 29141000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platelet reactivity as measured by plasma glycoprotein VI in gout.
    Conway R; Murphy CL; Madigan A; Kavanagh P; Geraghty L; Redmond N; Helbert L; Carey JJ; Dunne E; Kenny D; McCarthy GM
    Platelets; 2018 Dec; 29(8):821-826. PubMed ID: 29090618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection.
    O'Halloran JA; Dunne E; Gurwith M; Lambert JS; Sheehan GJ; Feeney ER; Pozniak A; Reiss P; Kenny D; Mallon P
    HIV Med; 2015 Nov; 16(10):608-19. PubMed ID: 26111187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porphyromonas gingivalis antibody levels and diagnosis of coronary artery disease in HIV-positive individuals.
    Berquist VL; Hearps AC; Ford P; Jaworowski A; Leishman SJ; Hoy JF; Trevillyan JM
    J Periodontal Res; 2017 Oct; 52(5):930-935. PubMed ID: 28397248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of soluble glycoprotein VI, a potential platelet activation biomarker.
    Naitoh K; Hosaka Y; Honda M; Ogawa K; Shirakawa K; Furusako S
    Platelets; 2015; 26(8):745-50. PubMed ID: 25549161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of soluble EMMPRIN (CD147) correlate with levels of soluble glycoprotein VI in human plasma.
    Pennings GJ; Yong AS; Wong C; Al-Tamimi M; Gardiner EE; Andrews RK; Kritharides L
    Platelets; 2014; 25(8):639-42. PubMed ID: 24245520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke.
    Al-Tamimi M; Gardiner EE; Thom JY; Shen Y; Cooper MN; Hankey GJ; Berndt MC; Baker RI; Andrews RK
    Stroke; 2011 Feb; 42(2):498-500. PubMed ID: 21193745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy.
    Yamashita Y; Naitoh K; Wada H; Ikejiri M; Mastumoto T; Ohishi K; Hosaka Y; Nishikawa M; Katayama N
    Thromb Res; 2014 Mar; 133(3):440-4. PubMed ID: 24325877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVI.
    Montague SJ; Delierneux C; Lecut C; Layios N; Dinsdale RJ; Lee CS; Poulter NS; Andrews RK; Hampson P; Wearn CM; Maes N; Bishop J; Bamford A; Gardiner C; Lee WM; Iqbal T; Moiemen N; Watson SP; Oury C; Harrison P; Gardiner EE
    Blood Adv; 2018 Feb; 2(3):240-251. PubMed ID: 29437639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sandwich immunoassay for soluble glycoprotein VI in patients with symptomatic coronary artery disease.
    Bigalke B; Pötz O; Kremmer E; Geisler T; Seizer P; Puntmann VO; Phinikaridou A; Chiribiri A; Nagel E; Botnar RM; Joos T; Gawaz M
    Clin Chem; 2011 Jun; 57(6):898-904. PubMed ID: 21474641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shedding of soluble glycoprotein VI is neither affected by animal-derived antibeta-2-glycoprotein 1 antibodies nor IgG fractions from patients with systemic lupus erythematosus.
    Ho YC; Ahuja KDK; Andrews RK; Adams MJ
    Blood Coagul Fibrinolysis; 2020 Jun; 31(4):258-263. PubMed ID: 32205472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease.
    Laske C; Leyhe T; Stransky E; Eschweiler GW; Bueltmann A; Langer H; Stellos K; Gawaz M
    J Psychiatr Res; 2008 Jul; 42(9):746-51. PubMed ID: 17854831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke.
    Wurster T; Poetz O; Stellos K; Kremmer E; Melms A; Schuster A; Nagel E; Joos T; Gawaz M; Bigalke B
    Platelets; 2013; 24(7):560-5. PubMed ID: 23215725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban.
    Aota T; Naitoh K; Wada H; Yamashita Y; Miyamoto N; Hasegawa M; Wakabayashi H; Yoshida K; Asanuma K; Matsumoto T; Ohishi K; Shimokariya Y; Yamada N; Nishikawa M; Katayama N; Uchida A; Sudo A
    Int J Hematol; 2014 Nov; 100(5):450-6. PubMed ID: 25253166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble glycoprotein VI is a predictor of major bleeding in patients with suspected heparin-induced thrombocytopenia.
    Pishko AM; Andrews RK; Gardiner EE; Lefler DS; Cuker A
    Blood Adv; 2020 Sep; 4(18):4327-4332. PubMed ID: 32915974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Soluble Platelet Glycoprotein VI Levels in Patients After Living Donor Liver Transplantation.
    Takahashi N; Usui M; Naitoh K; Wada H; Mastsui T; Kobayashi T; Matsumoto T; Uemoto S; Isaji S
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):274-281. PubMed ID: 26346441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of receptor shedding-platelet GPVI as an emerging diagnostic and therapeutic tool.
    Chatterjee M; Gawaz M
    Platelets; 2017 Jun; 28(4):362-371. PubMed ID: 27753514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble sortilin is released by activated platelets and its circulating levels are associated with cardiovascular risk factors.
    Ogawa K; Ueno T; Iwasaki T; Kujiraoka T; Ishihara M; Kunimoto S; Takayama T; Kanai T; Hirayama A; Hattori H
    Atherosclerosis; 2016 Jun; 249():110-5. PubMed ID: 27085161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection.
    Nkambule BB; Davison G; Ipp H
    Platelets; 2015; 26(3):250-7. PubMed ID: 24831969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.